Page URL:

Genes affect response to cholesterol-lowering drugs

18 June 2004
By BioNews
Appeared in BioNews 263

Genes can affect a person's response to statins, drugs used to lower blood cholesterol levels, say US researchers. Researchers at the Brigham and Women's Hospital in Boston say their study shows that knowledge about the interaction between genes and drugs is growing 'in leaps and bounds'. Their findings, published in the Journal of the American Medical Association, show that particular variations in a single gene are linked to a reduced response to the drug pravastatin.

Many scientists predict that pharmacogenetics - the use of genetic tests to match medicines to a person's genetic make-up - will revolutionise health care in the future. However, only a handful of the genetic variations linked to adverse reactions or a reduced response to a particular drug have so far been identified. The latest study looked at 1,563 people taking pravastatin, prescribed to lower cholesterol levels. Statins work by blocking the action of a protein called HMG-CoA reductase gene, which in turn lowers levels of both total and so-called 'bad' low density lipoprotein (LDL) cholesterol. The scientists found that people with variations in the HMG-CoA reductase gene had a 22 per cent smaller reduction in total cholesterol, and a 19 per cent smaller reduction in LDL cholesterol, compared to those who did not have the gene variants.

Around seven per cent of the study participants had the genetic variations associated with a reduced response to pravastatin. Team leader Paul Ridker is not surprised by the findings, saying that 'we've known for some time that some patients get a greater reduction than others'. But the results do not call for any major change in treating patients, he says, adding that 'it could well be that just a higher dose will overcome this problem'. According to Susanne Haga, who wrote an editorial accompanying the report, 'information on how genetic variation affects drug efficacy and drug safety will become a basic part of drug development'. But she added that, at the moment, 'the commercial ability to test for these variations is not available'.

Genes explain statins' success
Nature News |  16 June 2004
Genetic test indicates drugs could be tailored to patient, report says
The Boston Globe |  16 June 2004
Pharmacogenetic study of statin therapy and cholesterol reduction
Journal of the American Medical Association |  16 June 2004
Statins are not
New Scientist |  15 June 2004
28 September 2009 - by Dr Aarathi Prasad 
A new NHS-funded study will test patients for genes that may play a key role in side-effects related to statin use....
28 July 2008 - by Ailsa Stevens 
A rare but serious side effect experienced by people taking the cholesterol-lowering drugs statins may be avoided in up to 60 per cent of cases, according to research published in the New England Journal of Medicine last week. The University of Oxford-based research team identified a gene...
15 July 2005 - by BioNews 
Doctors at two UK hospitals have launched a trial project to identify people with a hereditary condition that causes very high blood cholesterol, which increases their risk of having a heart attack. The Royal Surrey County Hospital and Frimley Park Hospital in Hampshire are together one of five pilot centres...
11 July 2005 - by BioNews 
A study of identical twins in the US suggests why some people can eat all the fatty foods they want without increasing their blood cholesterol levels, while others have to watch their diets like a hawk. The researchers found that people's genes play a more important role than lifestyle in...
23 June 2004 - by BioNews 
Research into pharmacogenetics - the use of genetic tests to match medicines to a person's genetic make-up - is to receive £4 million of funding, Health Minister Lord Warner announced last week. The cash will go to six different research projects, which include studies on medicines used to prevent blood clots, epilepsy...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.